EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSTOG00000004062
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Protease Regulatory Subunit 4 Pseudogene

Ensembl ID : ENSSTOG00000032909
Gene Symbol: LOC101972090
1 Cross references
175 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSSTOG00000009610
Gene Symbol: HMGCR
4 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSSTOG00000013009
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSSTOG00000027549
Gene Symbol: LOC101957153
3 Cross references
202 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSSTOG00000021683
Gene Symbol: LOC101977469
1 Cross references
201 Possible Orthologues:

40s Ribosomal Protein S15a Pseudogene

Ensembl ID : ENSSTOG00000032770
Gene Symbol: LOC101967708
1 Cross references
59 Possible Orthologues:

40s Ribosomal Protein S2 Pseudogene

Ensembl ID : ENSSTOG00000008188
Gene Symbol: LOC101966390
1 Cross references
143 Possible Orthologues:

40s Ribosomal Protein S20-Like

Ensembl ID : ENSSTOG00000027244
Gene Symbol: LOC101961988
2 Cross references
131 Possible Orthologues:

40s Ribosomal Protein S27

Ensembl ID : ENSSTOG00000031138
Gene Symbol: LOC101971714
3 Cross references
115 Possible Orthologues:

40s Ribosomal Protein S4, X Isoform-Like

Ensembl ID : ENSSTOG00000028692
Gene Symbol: LOC101956897
3 Cross references
185 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSSTOG00000004141
Gene Symbol: NT5E
4 Cross references
247 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).